April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Novel Pentablock Copolymer Based Nanoformulations for Sustained Ocular Delivery of Protein Therapeutics
Author Affiliations & Notes
  • VIBHUTI AGRAHARI
    Division of Pharmaceutical Sciences, University of Missouri Kansas City, Kansas City, MO
  • Sulabh P Patel
    Division of Pharmaceutical Sciences, University of Missouri Kansas City, Kansas City, MO
  • Ashim K Mitra
    Division of Pharmaceutical Sciences, University of Missouri Kansas City, Kansas City, MO
  • Footnotes
    Commercial Relationships VIBHUTI AGRAHARI, None; Sulabh Patel, None; Ashim Mitra, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 4628. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      VIBHUTI AGRAHARI, Sulabh P Patel, Ashim K Mitra; Novel Pentablock Copolymer Based Nanoformulations for Sustained Ocular Delivery of Protein Therapeutics. Invest. Ophthalmol. Vis. Sci. 2014;55(13):4628. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: In this study, protein encapsulated sustained release nanoformulation has been synthesized and evaluated using novel tailor made pentablock (PB) copolymer for the treatment of posterior segment eye diseases. The effect of block arrangements of PB copolymers on encapsulation efficiency (EE), drug loading (DL) and release profile was studied.

Methods: Hydrophobic and hydrophilic PB copolymers with different block ratios of PEG/PCL/PLA were synthesized by ring-opening copolymerization method and characterized by 1H-NMR spectroscopy, gel permeation chromatography (GPC) and X-ray diffraction (XRD) analysis. The hydrophobic PB copolymer (PCL-PLA-PEG-PLA-PCL) was utilized to prepare nanoparticles (NPs) while hydrophilic polymer (PEG-PCL-PLA-PCL-PEG) was used for the preparation of thermosensitive gel. The NP preparation method was optimized to improve entrapment efficiency (EE) and drug loading (DL) of protein macromolecules. Cytotoxicity (MTS and LDH) assays were performed on HCEC and ARPE-19 cell lines to study the in vitro cell viability. In addition, biocompatibility study of the PB copolymers was evaluated on macrophage (RAW 264.7) cell line.

Results: The molecular weight and purity of the PB copolymers were confirmed by 1H-NMR and GPC. XRD study revealed that the arrangement of polymeric blocks controls the crystalline or amorphous nature of PB copolymer. The solvent evaporation (W1/0/W2) NP preparation method was successfully optimized and a remarkably improved EE (~ 46% to 76%) and DL (~15% to 18%) have been observed. Results of in vitro studies depicted zero ordered drug release of NPs for a significantly longer period of time (~ 90 days) without showing any burst release effect. PB copolymers demonstrated higher cell viability on HCEC and ARPE-19 cell lines. The in vitro biocompatibility assay exhibited negligible release of cytokines suggesting the biocompatible nature of PB copolymers.

Conclusions: Novel PB copolymer based nanoformulations were successfully prepared and optimized. Results showed that the PB copolymers can be used as a platform for the treatment of posterior segment ocular diseases.

Keywords: 607 nanotechnology • 608 nanomedicine  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×